Proposed Workshop: Hemoglobin Standards and Maintenance of Iron Stores in Blood Donors Blood Product Advisory Committee April 29, 2011.

Slides:

Advertisements

Similar presentations

Maintaining a Safe and Adequate Supply of Donated Blood During a Severe Emergency Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs, OBRR,

Advertisements

Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD.

Blood Donor Written Statement of Understanding

Public Workshop: Quarantine Release Errors in Blood Establishments September 13, 2011 QREs Past, Present and Future Sheryl A. Kochman Deputy Director Division.

Chubaka Producciones Presenta :.

Greater Sage-Grouse Conservation Assessment and Strategy for Oregon Rules Amendment s.

Iron Status in Blood Donors Barbara J. Bryant, MD University of Texas Medical Branch Galveston, Texas and Department of Transfusion Medicine National Institutes.

Clinical and Surrogate Endpoints for Evaluating Efficacy of Alpha 1 - Proteinase Inhibitor (Human) Augmentation Therapy Topic II - Introduction Blood Products.

2012 JANUARY Sun Mon Tue Wed Thu Fri Sat

P Pathophysiology Calendar. SundayMondayTuesdayWednesdayThursdayFridaySaturday January 2012.

Strategy Maps for Structuring Program Operating Plans: Family Planning Examples Public Health Foundation Paul Epstein, Results That Matter Team Kentucky.

Current standards, donor safety, and blood supply

1 Babesia BPAC: FDA Perspective Sanjai Kumar, PhD Division of Emerging and Transfusion- Transmitted Diseases Office of Blood Research and Review CBER,

Rebecca Dunham Karen Salamat Danielle Wilson.  8Vw 8Vw.

Screening for HBsAg and Anti-HBc in North American Blood Donors John Saldanha, Roche Molecular Systems SoGAT XXI, May, 2009, Brussels, Belgium.

CBER 1 Current standards, donor safety and blood supply Orieji Illoh, MD Office of Blood Research and Review Center for Biologics Evaluation and Research.

Parvovirus B19 NAT for Whole Blood and Source Plasma Introduction and Background Mei-ying W Yu, PhD DH/OBRR/CBER/FDA 75 th Blood Products Advisory Committee.

CBER Hemoglobin/Hematocrit Acceptance Standards and Interdonation Interval in Blood Donors Introduction Blood Products Advisory Committee July 27, 2010.

CBER Hemoglobin/Hematocrit Acceptance Standards and Interdonation Interval in Blood Donors Summary and Questions for the Committee Blood Products Advisory.

Proposed changes to hemoglobin and donation interval criteria for whole blood donors: Projected impact on current donor base Anne Eder, MD PhD Executive.

History of Project Joint interest in sea turtle conservation identified at the 8 th LMR Panel Meeting (June 2011) Focus on green sea turtles, loggerheads.

Reentry for Donors Deferred Based on Anti-HBc Test Results November 3, 2005 BPAC Meeting FDA/CBER/OBRR/DETTD.

FDA’s Current Considerations of Parvovirus B19 Nucleic Acid Testing (NAT) Mei-ying W. Yu, PhD Division of Hematology CBER/FDA Extraordinary SoGAT Meeting.

Challenges in evaluating and changing donor criteria Dr. Mindy Goldman Transfusion Medicine Residents April 30, 2008.

John Teaching Calendar. NIV Comm April 2006 MondayTuesdayWednesdayThursdayFridaySaturdaySunday (1:1– 18) Dan.

Current Considerations on Plasma for Further Manufacturing Obtained from Whole Blood Donors Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs,

Homeland Security Grant Program 2015 Process Michelle Hanneken Illinois Emergency Management Agency.

Monthly Journal article review: Vimmi Kang PGY 2

Kingsclear Consolidated School Parent / Community Meeting November 29, 2010.

Current Status of Issues Related to West Nile virus testing and donor screening Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.

UNAIDS Program Coordinating Board Meeting 10 December 2009 Geneva The Impact of the Global Economic Crisis on HIV and AIDS.

Abbreviated Donor History Questionnaire: Background and Introduction Sharyn Orton, Ph.D. OBRR/CBER/FDA Blood Products Advisory Committee March 2005.

WORD JUMBLE. Months of the year Word in jumbled form e r r f b u y a Word in jumbled form e r r f b u y a february Click for the answer Next Question.

Blood Center Experience with Double Red Cell Collections by Apheresis: Adverse Events and Impact on Capacity Brian Custer, Hany Kamel, Marj Bravo Peter.

DATE POWER 2 INCOME JANUARY 100member X 25.00P2, FEBRUARY 200member X 25.00P5, MARCH 400member X 25.00P10, APRIL 800member.

ANAEMIA ŞİFA-TUĞÇE.

Most genes have more than two alleles for the same character.

David A. Gerber, MD Professor and Chief Division of Abdominal Transplantation Department of Surgery University of North Carolina at Chapel Hill.

2011 Calendar Important Dates/Events/Homework. SunSatFriThursWedTuesMon January

HHS Secretary’s Advisory Committee on Blood Safety and Availability Summary for FDA’s BPAC July 2010 Jerry A. Holmberg, Ph.D. Senior Advisor for Blood.

FDA Perspective on the PASSPORT Study FDA Perspective on the PASSPORT Study Salim A. Haddad, M.D. Laboratory of Cellular Hematology Division of Hematology.

Accountability Update District Advisory Council January 7, 2016.

Texas Department of Transportation Corpus Christi District U.S. 181 (Harbor Bridge) Environmental Documentation and Schematic Development Citizens’ Advisory.

Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection - Update - Alan E. Williams, Ph.D. Director,

HHS Secretary’s Advisory Committee on Blood Safety and Availability Summary of November 2010 ACBSA for FDA’s BPAC December 2010 CDR Richard Henry, USPHS.

July 2007 SundayMondayTuesdayWednesdayThursdayFridaySaturday

Presenting Author: Dr. Sathyabhama S. Co-authors: Dr. Jaisy Mathai Dr. P.V. Sulochana Mr. Vimal Sathyan Sree Chitra Tirunal Institute for Medical Sciences.

Workshop 2 Chair: Martin Birley Health Impact Assessment: Making the Difference.

CBER Current Considerations for Blood Donor Screening for West Nile Virus Pradip N. Akolkar, Ph.D. Maria Rios, Ph.D. DETTD, OBRR Blood Products Advisory.

Mobile Health 2017 Calendar of Monthly Awareness Messages

Lessons-learned Add Title

McDonald’s Kalender 2009.

McDonald’s Kalender 2009.

NATA Foundation Building Blocks Process

McDonald’s Kalender 2009.

What is Patient Blood Management?

McDonald’s calendar 2007.

Strategic Planning Timeline Overview

Development of energy balance statistics

Dr. Nishi Jaswal Assistant Professor

Tropical cyclones movement

February 2007 Note: Source:.

The number of subjects by year (1) assessed in the iron deficiency anaemia clinic and (2) admitted (overnight or day-case) for blood transfusion to treat.

McDonald’s calendar 2007.

The number of subjects by year (1) assessed in the iron deficiency anaemia clinic and (2) admitted (overnight or day-case) for blood transfusion to treat.

Habitat Changes and Fish Migration

2015 January February March April May June July August September

Habitat Changes and Fish Migration

Presentation transcript:

Proposed Workshop: Hemoglobin Standards and Maintenance of Iron Stores in Blood Donors Blood Product Advisory Committee April 29, 2011

Interest in this Topic June, 2001: Workshop: Maintaining Iron Balance in Women Blood Donors of Child Bearing Age. June, 2001: Workshop: Maintaining Iron Balance in Women Blood Donors of Child Bearing Age. September, BPAC. Donor hemoglobin acceptance standards. September, BPAC. Donor hemoglobin acceptance standards. December, ACBSA. Donor hemoglobin acceptance standards. December, ACBSA. Donor hemoglobin acceptance standards. July, BPAC. Hemoglobin/hematocrit acceptance standards and interdonation interval in blood donors. July, BPAC. Hemoglobin/hematocrit acceptance standards and interdonation interval in blood donors. REDS II Donor Iron Status Evaluation Study. REDS II Donor Iron Status Evaluation Study. Cable et al. Transfusion 2011;51: Cable et al. Transfusion 2011;51:

Workshop Goals Discuss donor hemoglobin standards and measurement and to determine how any change in hemoglobin standards may affect donor safety and the blood supply. Discuss donor hemoglobin standards and measurement and to determine how any change in hemoglobin standards may affect donor safety and the blood supply. Review data on the impact of donation on iron stores, and techniques to assess iron stores in donors. Review data on the impact of donation on iron stores, and techniques to assess iron stores in donors. Assess measures to mitigate donor iron loss, such as iron supplementation or change in the interdonation interval. Evaluate how any such change may affect the blood supply. Assess measures to mitigate donor iron loss, such as iron supplementation or change in the interdonation interval. Evaluate how any such change may affect the blood supply.

Topics to be Addressed Hemoglobin standards for blood donors Hemoglobin standards for blood donors Measurement of hemoglobin and iron in blood donors Measurement of hemoglobin and iron in blood donors Iron stores and iron deficiency in blood donors Iron stores and iron deficiency in blood donors Iron supplementation strategies for blood donors Iron supplementation strategies for blood donors Impact of any change in hemoglobin standards or interdonation interval on the blood supply and on blood establishment operations. Impact of any change in hemoglobin standards or interdonation interval on the blood supply and on blood establishment operations.